Category Archives: Doctrine of equivalents

Intel’s literal infringement affirmed; DOE infringement and damages reversed; denial of license defense reversed

Posted on December 21, 2023 by Patrick J. Halloran, Ph.D., J.D.

VLSI Technology LLC v. Intel Corporation Docket No. 2022-1906 (https://cafc.uscourts.gov/opinions-orders/22-1906.OPINION.12-4-2023_2231550.pdf) LOURIE, DYK, TARANTO December 4, 2023 Brief Summary:  Literal infringement finding affirmed for one of VLSI’s patent, infringement under DOE reversed for the other, with its damages award; DC denial … Continue reading →

Posted in Damages, Doctrine of equivalents, Infringement, Royalties | Leave a comment

DC grant of PI vacated and remanded as Lite-Netics’ infringement allegations not objectively baseless (First Amendment issues relating to customer letters addressed)

Posted on February 23, 2023 by Patrick J. Halloran, Ph.D., J.D.

Lite-Netics, LLC v. Nu Tsai Capital LLC, Holiday Bright Lights (“HBL”) Docket No. 2023-1146 (h https://cafc.uscourts.gov/opinions-orders/23-1146.OPINION.2-17-2023_2082508.pdf) LOURIE, TARANTO, STARK February 17, 2023 Brief Summary:   DC grant of PI vacated and remanded based on the DC’s abuse of discretion in … Continue reading →

Posted in Claim Construction, Doctrine of equivalents, Infringement, Injunction, Prosecution History Estoppel | Leave a comment

DC erred in granting SJ of noninfringement as claim construction “dependent on the way the claimed cassette is put to use in an unclaimed structure and erroneous function-way-result analysis

Posted on March 12, 2021 by Patrick J. Halloran, Ph.D., J.D.

Edgewell Personal Care Brands, LLC et al. v. Munchkin, Inc. Docket No. 2020-1203 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1203.OPINION.3-9-2021_1745042.pdf) NEWMAN, MOORE, HUGHES March 9, 2021 Brief Summary:  DC grant of SJ vacated-in-part, reversed-in-part and remanded (claim construction “dependent on the way the claimed cassette is … Continue reading →

Posted in Claim Construction, Doctrine of equivalents | Leave a comment

DC grant of SJ of infringement to Lilly under DOE affirmed

Posted on December 31, 2020 by Patrick J. Halloran, Ph.D., J.D.

Eli Lilly And Company v. Apotex, Inc. Docket No. 2020-1328 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1328.OPINION.12-21-2020_1705369.pdf) PROST, BRYSON, STOLL December 21, 2020 Non-precedential Brief Summary:  DC grant of SJ of infringement under DOE affirmed. Summary:  Apotex appealed DC grant of Lilly’s motion for summary judgment … Continue reading →

Posted in Doctrine of equivalents, Generics / ANDA, Indefiniteness, Prosecution History Estoppel | Leave a comment

DC infringement decision affirmed for one patent, preambles found limiting as to two others, money damages affirmed, injunction for two of four accused products vacated

Posted on August 18, 2020 by Patrick J. Halloran, Ph.D., J.D.

Bio-Rad Labs., Inc., The Univ. of Chicago v. 10X Genomics Inc. Docket No. 2019-2255, -2285 NEWMAN, O’MALLEY, TARANTO August 3, 2020 Brief Summary: DC decision of infringement of ‘083 patent under DOE affirmed; preamble found to limit ‘407 and ‘193 … Continue reading →

Posted in Claim Vitiation, Damages, Doctrine of equivalents, Infringement, Willfullness | Leave a comment

DC non-infringement decision affirmed due to disclosure-dedication doctrine

Posted on May 11, 2020 by Patrick J. Halloran, Ph.D., J.D.

Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC Docket No. 2019-1924 O’MALLEY, REYNA, CHEN May 8, 2020 Brief Summary: DC finding of no infringement under DOE based on disclosure-dedication doctrine affirmed. Summary: Eagle appealed DC judgment of non-infringement of US Pat. … Continue reading →

Posted in Claim Construction, Doctrine of equivalents, Infringement | Leave a comment

Injunction, damages, infringement and invalidity decisions regarding Illumina’s fetal testing patents affirmed

Posted on April 28, 2020 by Patrick J. Halloran, Ph.D., J.D.

Verinata Health, Inc., Illumina, Inc. v. Ariosa Diagnostics, Inc., Roche Mol. Sys., Inc. Docket No. 22018-2198, -2303, -2305, -2306, -2317 REYNA, WALLACH, HUGHES April 24, 2020 (Non-precedential) Brief Summary: DC denial of injunction and damages, as well as its refusal … Continue reading →

Posted in Anticipation (35 USC 102), Doctrine of equivalents, Enablement, Infringement, Software | Leave a comment

Rejected claim construction proposal during IPR was not prosecution history estoppel, FC affirms infringement under DOE; second infringement decision reversed

Posted on March 27, 2020 by Patrick J. Halloran, Ph.D., J.D.

Galderma Labs., Nestle Skin Health S.A. et al. v. Amneal Pharm. LLC et al. Docket No. 2019-1021 LOURIE, MOORE, STOLL March 25, 2020 Non-Precedential Brief Summary: DC finding of infringement of certain claims affirmed as statements made in related IPR … Continue reading →

Posted in Claim Construction, Doctrine of equivalents, Infringement, Inter Parties Review (IPR), IPR, Prosecution History Estoppel, Uncategorized | Leave a comment

DC grant of SJ of no literal or DOE infringement affirmed

Posted on December 9, 2019 by Patrick J. Halloran, Ph.D., J.D.

Plastic Omnium Advanced Innovation and Research v. Donghee America, Inc. et al. Docket Nos. 2018-2087 NEWMAN, CLEVENGER, REYNA December 3, 2019 Brief Summary: DC grant of SJ of no literal infringement or under the DOE affirmed based on DC claim … Continue reading →

Posted in Claim Construction, Doctrine of equivalents, Infringement, Uncategorized | Leave a comment

Infringement of analyte measurement device claims under DOE barred by prosecution history estoppel

Posted on November 25, 2019 by Patrick J. Halloran, Ph.D., J.D.

Pharma Tech Solutions, Inc. et al. v. LifeScan, Inc. (Johnson and Johnson) Docket Nos. 2019-1163 MOORE, REYNA, STOLL November 22, 2019 Brief Summary: DC grant of SJ of no infringement under DOE affirmed due to prosecution history estoppel. Summary: Pharma … Continue reading →

Posted in Doctrine of equivalents, Infringement, Prosecution History Estoppel, Uncategorized | Leave a comment